Martin Glegg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin Glegg has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- A Elliott
College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
1 shared publication - Allan James
Beatson West Scotland Canc Ctr, Dept Clin Oncol, Glasgow G12 0YN, Scotland
1 shared publication - Claire Paterson
Beatson West of Scotland Cancer Centre Glasgow UK
1 shared publication - Derek Grose
Beatson West of Scotland Cancer Centre, Glasgow, UK
1 shared publication - John Foster
Department of Clinical Physics and Bioengineering, Greater Glasgow Health Board and University of Glasgow, B15 2GW, UK
1 shared publication - Lye Mun Tho
Sunway Medical Centre, Selangor, 47500 Petaling Jaya, Selangor, Malaysia
1 shared publication
Latest Publications
- 1 July 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1051) , 20140645
A dual two dimensional electronic portal imaging device transit dosimetry model based on an empirical quadratic formalism
This study describes a two dimensional electronic portal imaging device (EPID) transit dosimetry model that can predict either: (1) in-phantom exit dose, or (2) EPID transit dose, for treatment verification. The model was based on a quadratic equation that relates the reduction in intensity to the equivalent path length (EPL) of the attenuator. In this study, two sets of quadratic equation coefficients were derived from calibration dose planes measured with EPID and ionization chamber in water under reference conditions. With two sets of coefficients, EPL can be calculated from either EPID or treatment planning system (TPS) dose planes. Consequently, either the in-phantom exit dose or the EPID transit dose can be predicted from the EPL. The model was tested with two open, five wedge and seven sliding window prostate and head and neck intensity-modulated radiation therapy (IMRT) fields on phantoms. Results were analysed using absolute gamma analysis (3%/3 mm). The open fields gamma pass rates were >96.8% for all comparisons. For wedge and IMRT fields, comparisons between predicted and TPS-computed in-phantom exit dose resulted in mean gamma pass rate of 97.4% (range, 92.3-100%). As for the comparisons between predicted and measured EPID transit dose, the mean gamma pass rate was 97.5% (range, 92.6-100%). An EPID transit dosimetry model that can predict in-phantom exit dose and EPID transit dose was described and proven to be valid. The described model is practical, generic and flexible to encourage widespread implementation of EPID dosimetry for the improvement of patients' safety in radiotherapy.
- 1 July 2015
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 88 (1051) , 20140645
A dual two dimensional electronic portal imaging device transit dosimetry model based on an empirical quadratic formalism
This study describes a two dimensional electronic portal imaging device (EPID) transit dosimetry model that can predict either: (1) in-phantom exit dose, or (2) EPID transit dose, for treatment verification. The model was based on a quadratic equation that relates the reduction in intensity to the equivalent path length (EPL) of the attenuator. In this study, two sets of quadratic equation coefficients were derived from calibration dose planes measured with EPID and ionization chamber in water under reference conditions. With two sets of coefficients, EPL can be calculated from either EPID or treatment planning system (TPS) dose planes. Consequently, either the in-phantom exit dose or the EPID transit dose can be predicted from the EPL. The model was tested with two open, five wedge and seven sliding window prostate and head and neck intensity-modulated radiation therapy (IMRT) fields on phantoms. Results were analysed using absolute gamma analysis (3%/3 mm). The open fields gamma pass rates were >96.8% for all comparisons. For wedge and IMRT fields, comparisons between predicted and TPS-computed in-phantom exit dose resulted in mean gamma pass rate of 97.4% (range, 92.3-100%). As for the comparisons between predicted and measured EPID transit dose, the mean gamma pass rate was 97.5% (range, 92.6-100%). An EPID transit dosimetry model that can predict in-phantom exit dose and EPID transit dose was described and proven to be valid. The described model is practical, generic and flexible to encourage widespread implementation of EPID dosimetry for the improvement of patients' safety in radiotherapy.
- Open Access
- 28 May 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 129
The influence of MRI scan position on patients with oropharyngeal cancer undergoing radical radiotherapy
The purpose of this study was to demonstrate how magnetic resonance imaging (MRI) patient position protocols influence registration quality in patients with oropharyngeal cancer undergoing radical radiotherapy and the consequences for gross tumour volume (GTV) definition and radiotherapy planning.
- 28 May 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 129
Open AccessThe influence of MRI scan position on patients with oropharyngeal cancer undergoing radical radiotherapy
The purpose of this study was to demonstrate how magnetic resonance imaging (MRI) patient position protocols influence registration quality in patients with oropharyngeal cancer undergoing radical radiotherapy and the consequences for gross tumour volume (GTV) definition and radiotherapy planning.